Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2012-07-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
《嘉事堂药业股份有限公司章程》修订对照表
Governance Information Classification · 95% confidence The document is titled as a revision comparison table for the Articles of Association (章程) of 嘉事堂药业股份有限公司. It details changes in company governance structure, management roles, supervisory board composition, and profit distribution policies. This type of document is focused on governance rules and company internal regulations rather than financial results or announcements. It does not contain financial statements or earnings data, nor is it an announcement of a report. The content aligns with governance information about the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length is short and focused on governance amendments, supporting this classification with high confidence.
2012-07-28 Chinese
拟聘任董事（含独立董事）、监事简历公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement listing the resumes of proposed directors (including independent directors) and supervisors for 嘉事堂药业股份有限公司. It includes biographical details, shareholding information, and confirms no regulatory penalties. There is no financial data, earnings information, or report content. The document is an announcement related to board/management changes, specifically the appointment of directors and supervisors. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 4953 characters, which is sufficient for a detailed announcement but not a full report. No indication of financial statements or report publication is present.
2012-07-28 Chinese
公司章程（2012年7月）
Governance Information Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司公司章程" which translates to "Cachet Pharmaceutical Co., Ltd. Articles of Association" or "Company Charter." The content includes detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, and procedures for shareholder meetings. It is a comprehensive governance document outlining the internal rules, structure, and operational guidelines of the company. There is no indication that this is an annual report, financial statement, earnings release, or any other type of financial or regulatory filing. Instead, it fits the description of a Governance Information report, which details the company's internal rules, board structure, and governance practices. The document length is substantial (15,000 characters), and it is not a brief announcement or certification. Therefore, the appropriate classification is Governance Information (CGR).
2012-07-28 Chinese
独立董事候选人声明（熊焰）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for the position. It includes detailed statements about the candidate's qualifications, independence, and adherence to relevant laws and regulations. There are no financial statements, earnings data, or report summaries. The content is focused on board/management information, specifically related to the nomination and qualifications of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed declarations rather than a brief announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2012-07-27 Chinese
独立董事候选人声明（刘建华）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of Jia Shi Tang Pharmaceutical Co., Ltd., affirming compliance with various legal and regulatory requirements for independent directors. It includes statements about independence, qualifications, and absence of conflicts of interest. There is no financial data, no mention of financial results, no report or presentation format, and no announcement of voting results or management changes. The document is a formal declaration related to board/management information, specifically concerning the appointment or candidacy of an independent director. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (4602 characters) and content support this classification with high confidence.
2012-07-27 Chinese
独立董事关于公司董事会相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on board-related matters, specifically regarding the nomination of board members and the approval of remuneration for the board and senior management. It references compliance with company bylaws and regulatory guidelines from the China Securities Regulatory Commission. The content focuses on governance and board composition rather than financial results or shareholder voting outcomes. The document length is short (1299 characters) and does not contain financial statements or detailed financial data. It is not an announcement of voting results but an opinion report related to board governance matters. Therefore, the most appropriate classification is Board/Management Information (MANG).
2012-07-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.